Eli Lilly LLY
NYSE LLY
$1,274.22 -32.52 (-2.49%)
At close: Oct 23, 2026 · 4:00 PM EDT

Eli Lilly (LLY) Asset Writedowns and Impairment (2011 - 2012)

Updated

Eli Lilly's Asset Writedowns and Impairment was $221 million in Q4 2012, down 26.9% from $302.5 million a year earlier.

Analysis

Eli Lilly (LLY) Asset Writedowns and Impairment (2011 - 2012) Analysis & Trends

For FY2012, Asset Writedowns and Impairment at Eli Lilly came in at $205 million, up 35.3% from FY2011.

  • In earlier years, Asset Writedowns and Impairment was $151.5 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Vertex Pharmaceuticals 132.74 Bn 104.74 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 221.00 Mn
Dec 31, 2011 302.50 Mn
API Access

Eli Lilly Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=LLY&period=max&api_key=YOUR_API_KEY